Coronavirus: Merck files for U.S. approval of its Covid pill

Sylvie Claire / October 11, 2021

The American laboratory Merck announced on Monday that it had filed an application for authorization with the American authorities for its pill against Covid-19, which could constitute a major advance in the fight against the pandemic.
 
The application is for Merck's drug molnupiravir for the treatment of adult patients with mild to moderate forms of Covid-19 who are at risk of progressing to severe forms and/or hospitalization, the company said in a statement.

 

      HTML Image as link                              

Related Posts

Jill and Joe Biden introduce Willow: Here's how the cat won the First Lady's heart
Jill and Joe Biden introduce Willow: Here's how the cat won the First Lady's heart
Steph Deschamps / January 29, 2022 She won Jill Biden's heart by interrupting a campaign speech: the First Lady ann...
Read More
European Medicines Agency approves Paxlovid, Pfizer's anti-Covid pill
European Medicines Agency approves Paxlovid, Pfizer's anti-Covid pill
Steph Deschamps / January 28, 2022 The European Medicines Agency (EMA) said Thursday it has approved Pfizer's anti-C...
Read More
Coronavirus: Biden administration withdraws mandatory vaccination in large companies
Coronavirus: Biden administration withdraws mandatory vaccination in large companies
Steph Deschamps / January 26, 2022   President Joe Biden's administration on Tuesday formally withdrew the vaccinatio...
Read More